newsfilter
← Latest News
GlobeNewswire·

SGRY Shareholders: Amparo Law Firm PLLC Is Investigating Whether Surgery Partners's $23.50-Per-Share Sale to HealthSpan Partners Delivers the Best Value for Shareholders

  • Amparo Law Firm PLLC is investigating whether Surgery Partners, Inc. (SGRY) shareholders can obtain more than $23.50 per share in a proposed take-private deal.
  • HealthSpan Partners, an affiliate of Bon Secours Mercy Health, agreed to acquire SGRY for an enterprise value of approximately $5.7 billion.
  • The deal offers $23.50 per share in cash to most shareholders, while Bain Capital affiliates will roll over shares into equity interests in the acquiring entity.
  • Bain Capital holds approximately 39% of SGRY outstanding shares \& has agreed to vote in favor of the transaction.
  • A Special Committee of independent directors unanimously recommended the deal, which was announced on October 26, 2026.
  • The investigation focuses on the sale process, financial advisor fees, potential ties to the buyer, \& whether the proxy statement meets Section 14(a) disclosure requirements.
  • A shareholder vote has not yet been scheduled, with an expected closing in the first quarter of 2027.
  • Amparo Investor Rights represents shareholders on a contingency basis with no upfront fees or costs.
  • The firm is led by Bob Amirian, Esq., \& is licensed to practice in New York, California, Texas, \& the District of Columbia.
Company
Amparo Law Firm
Keywords
Amparo Law Firm, Class Action